A tradition older than written record, still practiced today
Some scholars have linked small ceramic vessels from Ecuador, dated to around 2400 BCE, to ayahuasca ritual, though that reading is disputed; the firmest physical evidence so far is a roughly 1,000-year-old ritual bundle from a Bolivian rock shelter containing traces of both DMT and harmine (PNAS, 2019). Indigenous Amazonian peoples across present-day Peru, Brazil, Colombia, and Ecuador have used the brew for healing and spiritual purposes for centuries, quite possibly millennia. The name refers to a decoction traditionally made by combining the Banisteriopsis caapi vine with the leaves of Psychotria viridis (or related DMT-containing plants) — the vine supplies harmala alkaloids that inhibit the gut enzyme that would otherwise instantly break down the DMT in the leaves, allowing the DMT to actually reach the brain when taken by mouth. It's a functioning pharmacological solution that Western science only later explained in molecular terms.
From remote ceremony to global retreat industry
For most of its history, ayahuasca use was confined to Indigenous communities and the syncretic Brazilian churches (such as Santo Daime and União do Vegetal) that incorporated it into a Christian-influenced spiritual framework starting in the early-to-mid 20th century. That changed dramatically in recent decades: by 2019, at least 232 ayahuasca retreat centers were operating across Amazonian countries and Costa Rica, with Peru hosting the most of any country, driven by a wave of international "ayahuasca tourism." The typical modern tourist is different from a traditional participant in a telling way — split roughly evenly between men and women, averaging around age 35, and, by a two-to-one margin, holding at least a university degree — a demographic profile that looks a great deal like modern Western wellness-retreat tourism generally.
What the experience involves, and the real dangers
An ayahuasca ceremony typically lasts several hours, guided by an experienced facilitator (traditionally a shaman, though quality and training vary enormously in the modern tourism industry), and commonly involves intense visionary experiences, deep emotional processing, and — very commonly, and considered a normal, even therapeutic part of the process — vomiting or diarrhea, sometimes called "the purge." The real risks:
MAOI drug and food interactions are genuinely dangerous, not a minor caveat. Because ayahuasca contains real MAOIs, combining it with certain medications (notably SSRIs and other antidepressants, some other psychiatric medications, and certain other drugs) can cause serotonin syndrome, a potentially life-threatening reaction. Certain foods that are otherwise harmless can also cause dangerous interactions with MAOIs. This is a specific, well-documented pharmacological risk — not a vague spiritual caution — and it's the single most important safety fact in this piece.
Cardiovascular strain. The intensity of the experience, combined with vomiting and purging, can be physically demanding; ceremonies are generally not advisable for people with certain heart conditions.
Psychosis risk. As with other classic psychedelics, a personal or family history of psychosis is a serious contraindication — and case reports of ayahuasca-associated psychotic episodes do exist in the clinical literature, underscoring that this isn't a theoretical risk.
Wildly inconsistent facilitator quality. Unlike a hospital or a research trial, a retreat center's medical screening, facilitator training, and emergency preparedness vary enormously and are largely unregulated — the growth of the tourism industry has outpaced any consistent safety standard, and a genuinely important part of "informed" use is screening the retreat itself, not just the substance.
The most dangerous thing about ayahuasca usually isn't the ceremony itself — it's an unscreened medication interaction the retreat never asked about, or a facilitator with more marketing budget than actual training.
What the research shows on the benefit side
A growing body of research — including naturalistic studies conducted at real retreat centers rather than only in controlled labs — has found ayahuasca use associated with statistically significant reductions in depression and anxiety symptoms following a retreat, alongside a generally favorable pharmacological safety profile in screened, healthy participants. Ayahuasca and its component alkaloids are also being studied for potential benefit in substance use disorders. As with the rest of this category's psychedelics, the research base, while growing quickly, remains considerably smaller and less regulatorily advanced than psilocybin's.
An honest note on cultural context
Unlike most other substances in this category, ayahuasca arrives with a living Indigenous tradition attached to it, and a real, documented tension exists between that tradition and the modern global retreat industry — researchers and Indigenous advocates have raised specific concerns that many tourist-oriented "authentic" ceremonies borrow the aesthetics of Indigenous practice while disconnecting from its actual spiritual grounding, community context, and the economic benefit flowing back to source communities. Worth knowing, whatever you ultimately decide about your own interest in this substance.
Try this
If ayahuasca genuinely interests you, treat the medication-interaction question as non-negotiable before anything else — write out every medication and supplement you currently take and check it against a real MAOI interaction list, not a retreat center's own reassurance.
The takeaway
Ayahuasca combines two plants in a way that lets DMT survive digestion — a real, working pharmacological solution developed by Amazonian peoples over centuries, likely millennia, before modern chemistry could explain how it worked. It moved from Indigenous and syncretic-church use into a large global retreat tourism industry in recent decades, with quality and safety standards varying enormously between operators. Its most serious, well-documented danger is a MAOI interaction with certain medications and foods that can cause life-threatening serotonin syndrome — a specific pharmacological risk, not a vague caution. Naturalistic research shows real promise for depression and anxiety, alongside an honest, ongoing conversation about cultural appropriation in the modern tourism industry.
Try this: before any ayahuasca ceremony, check every medication and supplement you take against a real MAOI interaction list — this single check matters more than almost anything else in this piece.
Sources & Further Reading
Sources
- Historical and archaeological evidence of ayahuasca use, and its traditional plant combination and pharmacology, reflect published ethnobotanical and pharmacological research; the 1,000-year-old Bolivian bundle is Melanie J. Miller et al., PNAS, 2019, and the dispute over the 2400 BCE Ecuadorian vessels (Plutarco Naranjo, 1986) is summarised by the Chacruna Institute.
- Retreat center growth statistics and tourist demographic data reflect published 2019 ayahuasca tourism research (ICEERS).
- MAOI drug and food interaction risks and serotonin syndrome reflect standard clinical pharmacology and published case reports.
- Naturalistic-setting depression/anxiety outcome research reflects published studies including work published in Frontiers in Psychiatry.
- Cultural-appropriation concerns in the modern retreat industry reflect published academic and journalistic research on ayahuasca tourism.
Go deeper
- 🌐 Search "ayahuasca MAOI interaction dangerous drugs" for a full interaction list before considering any ceremony
- 🌐 ICEERS.org — the International Center for Ethnobotanical Education, Research and Service, a leading independent source on ayahuasca safety and context
- 🌐 Related piece in this library: DMT, this category, for the core psychoactive compound ayahuasca delivers